Loading…

MicroPort Medical announced its subsidiary will invest up to €25.3 million in Robocath, a French vascular robotics company, for a 23.19% stake. The parties also plan to form a joint venture in China to commercialize Robocath's R-One system.
“The investment and joint venture enable the Group to become a shareholder of Robocath, thereby promoting cooperation with Robocath to commercialize its highly innovative vascular robotic platform in the Chinese market.”zhitongcaijing.com
Summarized from public sources; check the original articles before acting on it.